Related Experiment Videos
ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis
Young-Mee Kim1,2, Seok-Jo Kim3,4, Ryosuke Tatsunami5,4
1Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia.
Abstract:
Reactive oxygen species (ROS) derived from NADPH oxidase (NOX) and mitochondria play a critical role in growth factor-induced switch from a quiescent to an angiogenic phenotype in endothelial cells (ECs). However, how highly diffusible ROS produced from different sources can coordinate to stimulate VEGF signaling and drive the angiogenic process remains unknown. Using the cytosol- and mitochondria-targeted redox-sensitive RoGFP biosensors with real-time imaging, here we show that VEGF stimulation in human ECs rapidly increases cytosolic RoGFP oxidation within 1 min, followed by mitochondrial RoGFP oxidation within 5 min, which continues at least for 60 min. Silencing of Nox4 or Nox2 or overexpression of mitochondria-targeted catalase significantly inhibits VEGF-induced tyrosine phosphorylation of VEGF receptor type 2 (VEGFR2-pY), EC migration and proliferation at the similar extent. Exogenous hydrogen peroxide (H2O2) or overexpression of Nox4, which produces H2O2, increases mitochondrial ROS (mtROS), which is prevented by Nox2 siRNA, suggesting that Nox2 senses Nox4-derived H2O2 to promote mtROS production. Mechanistically, H2O2 increases S36 phosphorylation of p66Shc, a key mtROS regulator, which is inhibited by siNox2, but not by siNox4. Moreover, Nox2 or Nox4 knockdown or overexpression of S36 phosphorylation-defective mutant p66Shc(S36A) inhibits VEGF-induced mtROS, VEGFR2-pY, EC migration, and proliferation. In summary, Nox4-derived H2O2 in part activates Nox2 to increase mtROS via pSer36-p66Shc, thereby enhancing VEGFR2 signaling and angiogenesis in ECs. This may represent a novel feed-forward mechanism of ROS-induced ROS release orchestrated by the Nox4/Nox2/pSer36-p66Shc/mtROS axis, which drives sustained activation of angiogenesis signaling program.
Insights
NADPH oxidase (NOX) and mitochondria-derived reactive oxygen species (ROS) drive angiogenesis. This study reveals a Nox4/Nox2/p66Shc pathway coordinating ROS production to sustain VEGF signaling and endothelial cell angiogenesis.
Area of Science:
- Cell Biology
- Biochemistry
- Physiology
Background:
- Reactive oxygen species (ROS) from NADPH oxidase (NOX) and mitochondria are crucial for endothelial cell (EC) angiogenic switching.
- The coordination of ROS from different sources to stimulate VEGF signaling in angiogenesis is not well understood.
Purpose of the Study:
- To elucidate the mechanism by which ROS sources coordinate to enhance VEGF signaling and angiogenesis in ECs.
- To investigate the roles of Nox4, Nox2, and p66Shc in ROS production and VEGF receptor signaling.
Main Methods:
- Real-time imaging using cytosol- and mitochondria-targeted redox-sensitive RoGFP biosensors in human ECs.
- Gene silencing (siRNA) of Nox4 and Nox2, and overexpression of mitochondria-targeted catalase.
- Assessment of VEGFR2 phosphorylation, EC migration, proliferation, and p66Shc phosphorylation.
Main Results:
- VEGF stimulation rapidly induced cytosolic and mitochondrial ROS production.
- Nox4-derived H2O2 activates Nox2, leading to increased mitochondrial ROS (mtROS) via pSer36-p66Shc.
- Knockdown of Nox4, Nox2, or p66Shc, or inhibition of p66Shc phosphorylation, impaired VEGF-induced angiogenesis.
Conclusions:
- A novel ROS-induced ROS release mechanism involving the Nox4/Nox2/pSer36-p66Shc/mtROS axis sustains VEGF signaling.
- This pathway is critical for driving sustained angiogenesis in endothelial cells.
- Targeting this axis may offer therapeutic strategies for angiogenesis-related diseases.